IMO the "street" sees no real "meat" in these PR's. We think it's great but the volume indicates there are no fresh buyers. It will most likely stay that way until there is a PR with "significant news". There is also a lot of interest in "shorting" and "optioning" the financials right now for some quick bucks. And it seems "quick" is the order of the day and "long" has too many uncertainties in a "uncertain" and "shaky" market conditions of late.
This stock is BB stock and people don’t like to keep their money in a BB stocks because BB stocks are notoriously unreliable and heavily manipulated. So they buy on good news and in anticipation of good news and sell when the news has gone a week or so. We saw that at the end of last week; the late week run up was an anticipation of big news today when it didn’t happen those people sold. There will be other news that will see a run up like more HIV results or the myriad of other results expected but they will not hold the value for the reasons stated above. We will see true run up and holding of value when we see money come into the company through these Pharma deals. When that happens the price will rise IMO to $5 and back to $3 and then hold for a few months and then as planned by NNVC and as previously discussed on this board NNVC will move to the NASDAQ. When that happens and the further developments that come along during that time the stock will then ascend to the levels that most holding this stock are expecting...the $30 to $200 range depending on progress, sales, if we are in a nuclear war etc etc...3-5 years SP at $30 - <$200 IMO
Market Data 
Markets 
AI
